Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Provention Bio Inc (NQ: PRVB ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 24.97 (100) Ask (Size) 25.05 (8) Prev. Close 24.98 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 94,780,874 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company? June 15, 2023 Company Moves Ahead With Drug Development Via Benzinga Provention Bio Inc. (NASDAQ: PRVB) Highlighted for Surprising Price Action April 26, 2023 Via Investor Brand Network Performance More News Read More Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis April 19, 2023 Via Benzinga Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise April 12, 2023 Via Benzinga Is Sanofi Stock a Buy Now? March 25, 2023 Via The Motley Fool Provention Bio's Earnings Outlook March 15, 2023 Via Benzinga 4 Analysts Have This to Say About Provention Bio March 14, 2023 Via Benzinga Provention Bio, Inc. (NASDAQ: PRVB) Making Surprising Moves in Monday Session March 13, 2023 Via Investor Brand Network Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information April 11, 2023 Via Benzinga PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB March 29, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health (NYSE – OSH), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL) March 23, 2023 From Brodsky & Smith LLC Via GlobeNewswire Top 5 Health Care Stocks That May Crash In March March 22, 2023 Via Benzinga Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review March 17, 2023 Via Investor's Business Daily Why Provention Bio Stock Skyrocketed 256% This Week March 16, 2023 Via The Motley Fool Why Shares of MacroGenics Climbed Thursday March 16, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023 March 15, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 March 14, 2023 Via Benzinga Top 5 Health Care Stocks That Are Ticking Portfolio Bombs March 14, 2023 Via Benzinga PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB March 13, 2023 From Kahn Swick & Foti, LLC Via Business Wire Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners March 13, 2023 Via The Motley Fool Nasdaq Up 150 Points; Gold Rises Over 2% March 13, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics (Nasdaq - XM), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL) March 13, 2023 From Brodsky & Smith LLC Via GlobeNewswire Sanofi (NASDAQ: SNY) Set to Acquire Provention Bio (NASDAQ: PRVB) for $2.9 Billion March 13, 2023 Via Spotlight Growth 12 Health Care Stocks Moving In Monday's Intraday Session March 13, 2023 Via Benzinga Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session March 13, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
